The Rose Breast Center has always been one of the leading providers of breast care in Colorado. By treating more breast cancer patients and providing the latest technologies and treatments, the Rose Breast Center is the place for women looking for their breast care provider.
We are excited to continue this tradition of excellence with three new exciting advancements in the diagnosis and treatment of breast cancer.
First, Rose became on of the first locations in Colorado to offer 3D Mammography – a technology called tomosynthesis. It offers exceptionally sharp images, providing the physician with better visualization and the patient with a reduced chance of callbacks for additional tests.
This state-of-the-art technology takes multiple, low-dose images of the breast from multiple angles (versus the traditional mammogram that takes two angles). These images then produce a series of one-millimeter thick slices that creates a 3D reconstruction of the breast. Currently, tomosynthesis is being done in addition to your routine screening mammogram to create a 3D mammogram of your breasts.
Second, Rose is the first hospital in Denver to offer the latest breakthrough in radiation therapy for breast cancer patients. The Xoft Axxent electronic brachytherapy (eBx) system involves precise placement of a radiation source internally, allowing for a high dose of radiation to be directed at a specific site within the body, while allowing greater protection of the normal tissues in the surrounding area. This technology gives eligible cancer patients a more convenient and comfortable alternative to traditional radiation therapy.
Xoft Axxent eBx technology also offers certain patients the possibility of Intraoperative Radiation Therapy (IORT), which delivers of the entire course of radiation therapy in the operating room at the time of surgery and can possibly eliminate the need for traditional daily outpatient treatments that could last 5-8 weeks.
Third, Rose is one of only a few hospitals in the country to participate in a trial for a new minimally invasive treatment for breast tumors. The Novilase® treatment has been approved for the removal of benign breast tumors, and now a trial is underway for malignant breast tumors.
This technology allows the physician to ablate the tumor in the breast with heat and energy from a small laser. This minimally invasive procedure takes less than an hour and only requires a lighter anesthesia, so it can be performed in our outpatient surgery setting. Novilase treatment also decreases the possible surgical risks and reduces the patient’s recovery time.
These are just a few of the many developments in store at Rose, and we are excited to begin offering these wonderful new diagnosis and treatment options to patients! For more information about the latest developments at the Rose Breast Center, please visit www.RoseBreastCenter.com.